0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hypertension has become one of the major public health problems in the world. At present, the pathogenesis of hypertension has still not been completely elucidated. In recent years, an increasing evidence shows that intestinal microecology is closely related to hypertension, which provides a new thinking for the prevention and treatment of hypertension. Traditional Chinese medicine (TCM) has unique advantages in the treatment of hypertension. Taking intestinal microecology as the target, it is possible to interpreting the scientific connotation of TCM prevention and treatment of hypertension by updating the treatment concept of hypertension, so as to improve the therapeutic effect. In our study, the clinical evidence for TCM treatment of hypertension was systematicly summarized. And the relationship among TCM, intestinal microecology and hypertension was analyzed. In addition, the methods by which TCM regulates intestinal microecology to prevent and treat hypertension were presented, to provide new research ideas for prevention and treatment of hypertension.

          Related collections

          Most cited references133

          • Record: found
          • Abstract: found
          • Article: found

          2018 ESC/ESH Guidelines for the management of arterial hypertension

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Structure, Function and Diversity of the Healthy Human Microbiome

            Studies of the human microbiome have revealed that even healthy individuals differ remarkably in the microbes that occupy habitats such as the gut, skin, and vagina. Much of this diversity remains unexplained, although diet, environment, host genetics, and early microbial exposure have all been implicated. Accordingly, to characterize the ecology of human-associated microbial communities, the Human Microbiome Project has analyzed the largest cohort and set of distinct, clinically relevant body habitats to date. We found the diversity and abundance of each habitat’s signature microbes to vary widely even among healthy subjects, with strong niche specialization both within and among individuals. The project encountered an estimated 81–99% of the genera, enzyme families, and community configurations occupied by the healthy Western microbiome. Metagenomic carriage of metabolic pathways was stable among individuals despite variation in community structure, and ethnic/racial background proved to be one of the strongest associations of both pathways and microbes with clinical metadata. These results thus delineate the range of structural and functional configurations normal in the microbial communities of a healthy population, enabling future characterization of the epidemiology, ecology, and translational applications of the human microbiome.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Clinical characteristics of 140 patients infected by SARS‐CoV‐2 in Wuhan, China

              Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS-CoV-2.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                31 May 2023
                2023
                : 14
                : 1171119
                Affiliations
                [1] 1 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine , National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion , Tianjin, China
                [2] 2 Institute of Traditional Chinese Medicine , Tianjin University of Traditional Chinese Medicine , Tianjin, China
                Author notes

                Edited by: Vincent Kam Wai Wong, Macau University of Science and Technology, Macao SAR, China

                Reviewed by: Kuiwu Yao, China Academy of Chinese Medical Sciences, China

                Jamal Alyoussef Alkrad, Isra University, Jordan

                Naina Mohamed Pakkir Maideen, Dubai Health Authority, United Arab Emirates

                *Correspondence: Xianliang Wang, xlwang1981@ 123456126.com ; Yi Wang, wangyi@ 123456tjutcm.edu.cn ; Jingyuan Mao, jymao@ 123456126.com
                [ † ]

                These authors have contributed equally to this work

                Article
                1171119
                10.3389/fphar.2023.1171119
                10264781
                37324472
                c2f14ea8-0415-4c3f-a593-f340b54c019c
                Copyright © 2023 Yang, Lin, Liu, Song, Ge, Fan, Chen, Bi, Zhao, Wang, Wang and Mao.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 21 February 2023
                : 15 May 2023
                Funding
                This work was supported by the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (No: ZYYCXTD-C-202203), the “Innovation Team Development Plan” of the Ministry of Education-Research on the Prevention and Treatment of Cardiovascular Diseases in Traditional Chinese Medicine (No: IRT_16R54).
                Categories
                Pharmacology
                Review
                Custom metadata
                Ethnopharmacology

                Pharmacology & Pharmaceutical medicine
                intestinal microecology,traditional chinese medicine,hypertension,gut microbiota,gut barrier,short chain fatty acids

                Comments

                Comment on this article